LV 901 Pill - yellow & white capsule/oblong, 17mm
Pill with imprint LV 901 is Yellow & White, Capsule/Oblong and has been identified as Oxycodone Hydrochloride 5 mg. It is supplied by Lehigh Valley Technologies, Inc.
Oxycodone is used in the treatment of Chronic Pain; Back Pain; Pain and belongs to the drug class Opioids (narcotic analgesics). FDA has not classified the drug for risk during pregnancy. Oxycodone 5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for LV 901
Oxycodone Hydrochloride
- Imprint
- LV 901
- Strength
- 5 mg
- Color
- Yellow & White
- Size
- 17.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Opioids (narcotic analgesics)
- Pregnancy Category
- N - Not classified
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Lehigh Valley Technologies, Inc.
- National Drug Code (NDC)
- 68462-0204 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
magnesium stearate,
microcrystalline cellulose,
corn starch,
sodium lauryl sulfate,
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
Related images for "LV 901"
More about oxycodone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,152)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
- En español
Patient resources
- Oxycodone drug information
- Oxycodone Capsules and Tablets
- Oxycodone Extended-Release Capsules
- Oxycodone Concentrate
- Oxycodone Solution
- Oxycodone Sustained-Release Tablets
Other brands
OxyContin, Roxicodone, Xtampza ER, Oxaydo, ... +8 more
Professional resources
- Oxycodone monograph
- Oxycodone (FDA)
- Oxycodone Capsules (FDA)
- Oxycodone ER (FDA)
- Oxycodone Extended-Release Tablets (FDA)
Other brands
OxyContin, Roxicodone, Xtampza ER, Oxaydo, RoxyBond
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
